Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Study 3033-2 | Other Identifier | Member Companies of the Opioid PMR Consortium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kaiser Permanente | OTHER |
| HealthCore, Inc. | INDUSTRY |
| Vanderbilt University | OTHER |
| World Health Information Science Consultants, LLC |
Not provided
Not provided
Not provided
Not provided
Not provided
Retrospective study to assess incidence and predictors of opioid abuse overdose and death associated with opioid overdose among patients prescribed opioid products in long-term use.
The purpose of this study is to quantify risk, and predictors of risks for opioid overdose and for death associated with opioid overdose in persons who are or have been long-term recipients of prescriptions for Schedule II opioids. The study uses coded terms in large heath databases maintained by healthcare providers and health insurers, supplemented by overdose deaths identified from the National Death Index. The terms for overdose are combined following validated rules as developed in companion studies. The study is being conducted in parallel with a prospective questionnaire-based cohort study of the same risks.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Long-term opioid-use cohort | Persons who have received 70 or more days of Schedule II opioid dispensed in a 90-day period, after at least 183 days with no opioid dispensing. |
| |
| IR/SA to ER/LA Switchers | Persons who have switched to or added on an ER/LA product after stable use of an IR/SA opioid regimen. |
| |
| IR/SA to IR/SA Switchers | Persons who have switched to or added on a new IR/SA opioid after stable use of a different IR/SA opioid regimen. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Observation only | Other | No intervention. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Opioid overdose - fatal and nonfatal | Opioid overdose as identified in insurance claims, electronic medical records and National Death Index records. | Retrospective review over period from October 1, 2006 to December 31, 2017 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Experience of opioid overdose in the six months preceding inclusion
Not provided
Not provided
The source populations will be those members of the selected health plans and insurance programs identified for which full demographic, provider, facility and pharmacy data are available, and in which protected health information (PHI) can be linked to death certificate information.
The four large healthcare systems that have established electronic databases for studying coded terminology outcomes selected for this study are: Kaiser Permanente Northwest; HealthCore, Inc. with access to commercial insurance data; Optum with access to commercial insurance data; and Vanderbilt University with access to Medicaid data for the State of Tennessee.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kenneth R Petronis | Epi Ideas LLC | Study Chair |
| John D Seeger | Optum, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| HealthCore Inc | Wilmington | Delaware | 19801 | United States | ||
| Optum |
Not provided
| ID | Term |
|---|---|
| D000083682 | Opiate Overdose |
| ID | Term |
|---|---|
| D062787 | Drug Overdose |
| D063487 | Prescription Drug Misuse |
| D000076064 | Drug Misuse |
| D019966 | Substance-Related Disorders |
Not provided
Not provided
| OTHER |
| Optum, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
| Boston |
| Massachusetts |
| 02215 |
| United States |
| Kaiser Permanente Northwest | Portland | Oregon | 97227 | United States |
| Vanderbilt University | Nashville | Tennessee | 37235 | United States |
| D064419 |
| Chemically-Induced Disorders |
| D009293 | Opioid-Related Disorders |
| D000079524 | Narcotic-Related Disorders |
| D001523 | Mental Disorders |